- Issuer ticker
-
CDLX
- Reported as of
-
12 Jan 2026
- Net transaction value
-
$0
- SEC form
-
3
- Accepted by SEC
-
16 Jan 2026, 16:51:29 UTC
Filing notes and source
Key filing fact
David Thomas Evans filed Form 3 for Cardlytics, Inc. (CDLX) on 16 Jan 2026.
Key facts
- This page summarizes David Thomas Evans's Form 3 filing for Cardlytics, Inc. (CDLX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Jan 2026, 16:51.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
Ownership activity is grounded in SEC Form 3 disclosures.
View source filing
Reporting Owners (1)
CIK 0001730451
Primary reporting owner
Evans David Thomas
- Relationship
-
Chief Financial Officer
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CDLX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
-
- Shares after
- 117,930
- Date
- 12 Jan 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney